JOSEPH FRESCURA: Open Payments
NPI 1437866720 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 50 payments from 20 companies in 2025. Trend: 2023 $36 · 2024 $1,848 · 2025 $1,229
Food & beverage: $1,229
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $153 |
| INTUITIVE SURGICAL, INC. | 1 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $100 |
| Lilly USA, LLC | 4 | $98 |
| Corcept Therapeutics | 4 | $97 |
| Mannkind Corporation | 4 | $95 |
| Tandem Diabetes Care, Inc. | 4 | $94 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $71 |
| Abbott Laboratories | 3 | $69 |
| ABBVIE INC. | 4 | $64 |
Products named: Da Vinci Surgical System, Kerendia, Korlym, AFREZZA, t:slim X2 Insulin Pump with Control-IQ, Ozempic, ISTURISA, FREESTYLE LIBRE 3.
Industry payments across IL — which companies pay providers there.
